These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20190962)

  • 1. The role of adenosine in Alzheimer's disease.
    Rahman A
    Curr Neuropharmacol; 2009 Sep; 7(3):207-16. PubMed ID: 20190962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A
    Merighi S; Borea PA; Varani K; Vincenzi F; Jacobson KA; Gessi S
    Curr Med Chem; 2022; 29(24):4138-4151. PubMed ID: 34844537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer's Disease.
    Cellai L; Carvalho K; Faivre E; Deleau A; Vieau D; Buée L; Blum D; Mériaux C; Gomez-Murcia V
    Front Neurosci; 2018; 12():520. PubMed ID: 30123104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological Role and Medicinal Chemistry of A
    Merighi S; Borea PA; Varani K; Vincenzi F; Travagli A; Nigro M; Pasquini S; Suresh RR; Kim SW; Volkow ND; Jacobson KA; Gessi S
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptor control of cognition in normal and disease.
    Chen JF
    Int Rev Neurobiol; 2014; 119():257-307. PubMed ID: 25175970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine for Prevention of Alzheimer's Disease: Is the A
    Merighi S; Travagli A; Nigro M; Pasquini S; Cappello M; Contri C; Varani K; Vincenzi F; Borea PA; Gessi S
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.
    Takahashi RN; Pamplona FA; Prediger RD
    Front Biosci; 2008 Jan; 13():2614-32. PubMed ID: 17981738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia.
    Espinosa J; Rocha A; Nunes F; Costa MS; Schein V; Kazlauckas V; Kalinine E; Souza DO; Cunha RA; Porciúncula LO
    J Alzheimers Dis; 2013; 34(2):509-18. PubMed ID: 23241554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline.
    Cunha RA; Agostinho PM
    J Alzheimers Dis; 2010; 20 Suppl 1():S95-116. PubMed ID: 20182043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.
    Cunha GM; Canas PM; Melo CS; Hockemeyer J; Müller CE; Oliveira CR; Cunha RA
    Exp Neurol; 2008 Apr; 210(2):776-81. PubMed ID: 18191838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
    Dall'Igna OP; Fett P; Gomes MW; Souza DO; Cunha RA; Lara DR
    Exp Neurol; 2007 Jan; 203(1):241-5. PubMed ID: 17007839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial Effect of a Selective Adenosine A
    Faivre E; Coelho JE; Zornbach K; Malik E; Baqi Y; Schneider M; Cellai L; Carvalho K; Sebda S; Figeac M; Eddarkaoui S; Caillierez R; Chern Y; Heneka M; Sergeant N; Müller CE; Halle A; Buée L; Lopes LV; Blum D
    Front Mol Neurosci; 2018; 11():235. PubMed ID: 30050407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes and Adenosine A
    Lopes CR; Cunha RA; Agostinho P
    Front Neurosci; 2021; 15():666710. PubMed ID: 34054416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and Structural Insight into Adenosine A
    Karati D; Mukherjee S; Roy S
    Mol Neurobiol; 2023 Oct; 60(10):5987-6000. PubMed ID: 37391647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of adenosine A
    Launay A; Nebie O; Vijaya Shankara J; Lebouvier T; Buée L; Faivre E; Blum D
    Neuropharmacology; 2023 Mar; 226():109379. PubMed ID: 36572177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review.
    Rivera-Oliver M; Díaz-Ríos M
    Life Sci; 2014 Apr; 101(1-2):1-9. PubMed ID: 24530739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine receptor signalling in Alzheimer's disease.
    Trinh PNH; Baltos JA; Hellyer SD; May LT; Gregory KJ
    Purinergic Signal; 2022 Sep; 18(3):359-381. PubMed ID: 35870032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine and coffee as therapeutics against Alzheimer's disease.
    Arendash GW; Cao C
    J Alzheimers Dis; 2010; 20 Suppl 1():S117-26. PubMed ID: 20182037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine Augmentation Evoked by an ENT1 Inhibitor Improves Memory Impairment and Neuronal Plasticity in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Lee CC; Chang CP; Lin CJ; Lai HL; Kao YH; Cheng SJ; Chen HM; Liao YP; Faivre E; Buée L; Blum D; Fang JM; Chern Y
    Mol Neurobiol; 2018 Dec; 55(12):8936-8952. PubMed ID: 29616397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.